Comparison of the safety and prognosis of sequential regorafenib after sorafenib and lenvatinib treatment failure in patients with unresectable hepatocellular carcinoma: a retrospective cohort study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.